EFFECT OF DRUG FORMULATION AND FEEDING ON THE PHARMACOKINETICS OF ORALLY-ADMINISTERED QUINIDINE IN THE HORSE

被引:11
作者
BOUCKAERT, S
VOORSPOELS, J
VANDENBOSSCHE, G
DEPREZ, P
REMON, JP
机构
[1] STATE UNIV GHENT,FAC PHARM,PHARMACEUT TECHNOL LAB,HARELBEKESTR 72,B-9000 GHENT,BELGIUM
[2] STATE UNIV GHENT,FAC VET MED,B-9000 GHENT,BELGIUM
关键词
D O I
10.1111/j.1365-2885.1994.tb00245.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quinidine is the drug of choice for the treatment of cardiac arrhythmias in horses. The plasma concentrations vs. time profiles following oral administration of two formulations of quinidine sulphate, an oral solution and an oral suspension paste, were evaluated in nine horses. They received multiple administrations of the oral solution under fed and non-fed conditions and of the paste under non-fed conditions. A loading dose of 20 mg.kg-1 and a maintenance dose of 10 mg.kg-1 quinidine with dosing interval of 6 h were used. The relative bioavailability of the oral solution under fed conditions in comparison to the solution under non-fed conditions was 75.0 +/- 10.2% for the loading dose and 97.18 +/- 31.66% after the fourth dose. For the paste formulation the relative bioavailability values are not reported, as steady-state levels were not reached. There was a large variation in plasma quinidine levels when the paste formulation was administered. Feeding conditions had a significant influence on the C(max) values after administration of the loading dose. The Tm. values were not affected by food intake. It was concluded that an oral solution has to be preferred because of the variable drug bioavailability from the paste formulation and the poor acceptability of the paste by the horse.
引用
收藏
页码:275 / 278
页数:4
相关论文
共 15 条
[1]   EFFECT OF FOOD AND AN ANTACID ON QUINIDINE BIOAVAILABILITY [J].
ACE, LN ;
JAFFE, JM ;
KUNKA, RL .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1983, 4 (02) :183-190
[2]  
DETWEILER DK, 1952, 89 P AM VET MED ASS, P119
[3]  
Frey H H, 1974, Berl Munch Tierarztl Wochenschr, V87, P245
[4]  
FREY W, 1918, BERL KLIN WCHNSCHR, V55, P450
[5]  
KURAKANE E, 1982, B EQUINE RES I, V19, P59
[6]   CLINICAL-PHARMACOLOGY AND THERAPEUTIC USES OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN THE HORSE [J].
LEES, P ;
HIGGINS, AJ .
EQUINE VETERINARY JOURNAL, 1985, 17 (02) :83-96
[7]   ABSORPTION AND PHARMACOKINETICS OF PHENYLBUTAZONE IN WELSH MOUNTAIN PONIES [J].
MAITHO, TE ;
LEES, P ;
TAYLOR, JB .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1986, 9 (01) :26-39
[8]  
MCGUIRK SM, 1981, AM J VET RES, V42, P938
[9]  
Roos J, 1924, HEART-J STUD CIRC, V11, P1
[10]   BIOAVAILABILITY OF PHENYLBUTAZONE PREPARATIONS IN THE HORSE [J].
ROSE, RJ ;
KOHNKE, JR ;
BAGGOT, JD .
EQUINE VETERINARY JOURNAL, 1982, 14 (03) :234-237